Skip to main content
. Author manuscript; available in PMC: 2014 Aug 14.
Published in final edited form as: Biol Psychiatry. 2012 Nov 28;73(12):1156–1163. doi: 10.1016/j.biopsych.2012.09.031

Figure 1.

Figure 1

Mean change in Montgomery-Åsberg Depression Rating Scale (MADRS) over sessions relative to the first baseline session is shown for the group who received placebo (P) in block 1 and scopolamine (S) in block 2 (P/S; red bars) and the group receiving scopolamine in block 1 and placebo in block 2 (S/P; blue bars). The 52 participants whose data are represented in this graph were pooled from the randomized controlled trials described in the text (31,43,44). Errors bars reflect standard error.